: Zevalin. ?  »
|
-

I.V

Kit For Radiopharmaceutical Preparation Infusion

The 90Y radiolabelled Zevalin is indicated as consolidation therapy after remission induction in previously untreated patients with follicular lymphoma. The benefit of Zevalin following rituximab in combination with chemotherapy has not been established.The 90Y - radiolabelled Zevalin is indicated for the treatment of adult patients with rituximab relapsed or refractory CD20+ follicular B-cell non-Hodgkin`s lymphama ( NHL).

133 71 31139 00

Spectrum Pharmaceuticals Cayman L.p , Islands

11/2010 - 11/2020

.
, .
.
/
Ibritumomab tiuxetan 1.6 MG/ML
Vial glass type i 4 x VIALS 48

*

*

 

.

...
 »
 
" !
 
233
, , ,